Back to home
BIIB logo

Is BIIB (Biogen Inc.) Halal or Haram?

NASDAQ Global SelectHealthcareDrug Manufacturers - General$27.97B2026-04-29
BIIB is Halal4/4 screens passed

Biogen Inc. successfully passes all AAOIFI shariah screening criteria, making it a halal investment. The company maintains a healthy balance sheet with a debt-to-market cap ratio of 24.8% and cash reserves at 13.6%, both well below the 33% threshold. Furthermore, its interest income is negligible at just 0.89% of total revenue, easily clearing the 5% limit.

Price Chart (5D)

$187.05+2.35 (+1.27%)
2026-05-012026-04-24

BIIB — Last 7 Days

DateOpenHighLowCloseVolumeChange
2026-05-01189.28190.57186.14187.06697K-1.17%
2026-04-30194.02195.98187.16189.281.6M-2.44%
2026-04-29183.12195.89180.18194.382.5M+6.15%
2026-04-28182.45184.41181.89183.381.2M+0.51%
2026-04-27183.16186.15179.15180.671.1M-1.36%
2026-04-24186.65186.65183.17184.38723K-1.22%
2026-04-23189.46190.32187.01187.88816K-0.83%

Discussion

Sign in to join the discussion

Loading comments...

Shariah Screening Details for BIIB

Business Activity

Permissible

Biogen's core business of developing therapies for neurological conditions like multiple sclerosis and Alzheimer's disease is fully permissible under Islamic guidelines, as it focuses on life-saving healthcare.

Debt / Market Cap

24.84%

Debt: $6.95BThreshold: ≤33%

Interest Income

0.89%

Interest: $87.8MThreshold: ≤5%

Cash & Securities

13.64%

Cash: $3.82BThreshold: ≤33%

About Biogen Inc. (BIIB)

Biogen Inc. is a leading biotechnology company that discovers, develops, and delivers therapies for severe neurological and neurodegenerative diseases. Its prominent portfolio includes multiple sclerosis treatments like TECFIDERA and AVONEX, as well as SPINRAZA for spinal muscular atrophy and ADUHELM for Alzheimer's disease.

For Muslim investors, Biogen represents a fully compliant healthcare stock, achieving a Halal status across all four AAOIFI screening criteria. The company's core operations in life-saving drug manufacturing align perfectly with Islamic ethical values, while its financial structure comfortably passes all screening thresholds.

From an Islamic finance perspective, Biogen showcases strong financial discipline with a debt-to-market cap ratio of 24.8%, keeping it safely below the 33% limit. Additionally, its interest-bearing securities and cash equivalents sit at a conservative 13.6%, and interest income is minimal at 0.89%, ensuring investors are largely shielded from riba-related earnings.

While Biogen's current operations and financials are clearly halal, Muslim investors should continue to monitor its debt levels during major acquisitions or clinical trial funding phases. Staying updated on their quarterly financial ratios will ensure the stock remains compliant within AAOIFI boundaries.

CEO

Christopher A. Viehbacher

Employees

7,605

IPO Date

1991-09-17

Headquarters

Cambridge, MA, US

BIIB Key Financial Statistics

Revenue

$9.81B

Net Income

$1.29B

EPS (Diluted)

$8.83

Stock Price

190.60

Beta

0.16

52-Week Range

115.25-202.41

Total Debt

$6.95B

Total Equity

$18.26B

Current Ratio

2.68

BIIB Financial Health & Profitability

Profit Margins

Gross Margin70.5%
Operating Margin19.1%
Net Margin13.2%

Revenue Growth (YoY)

+1.4%

Prior year: $9.68B

Net Debt

$3.94B

Cash: $3.01B — Debt: $6.95B

R&D Spending

$1.95B

% of Revenue

19.9%

Frequently Asked Questions About BIIB

Is BIIB (Biogen Inc.) stock halal to invest in?
Based on our AAOIFI-standard shariah screening, BIIB is Halal and considered permissible for Muslim investors. It passed all 4 of 4 compliance screens including business activity review, debt-to-market-cap ratio (24.84% vs ≤33% threshold), interest income ratio (0.89% vs ≤5% threshold), and cash & securities ratio (13.64% vs ≤33% threshold).
What does Biogen Inc. do?
Biogen Inc. is a leading biotechnology company that discovers, develops, and delivers therapies for severe neurological and neurodegenerative diseases. Its prominent portfolio includes multiple sclerosis treatments like TECFIDERA and AVONEX, as well as SPINRAZA for spinal muscular atrophy and ADUHELM for Alzheimer's disease. For Muslim investors, Biogen represents a fully compliant healthcare stock, achieving a Halal status across all four AAOIFI screening criteria. The company's core operations in life-saving drug manufacturing align perfectly with Islamic ethical values, while its financial structure comfortably passes all screening thresholds. From an Islamic finance perspective, Biogen showcases strong financial discipline with a debt-to-market cap ratio of 24.8%, keeping it safely below the 33% limit. Additionally, its interest-bearing securities and cash equivalents sit at a conservative 13.6%, and interest income is minimal at 0.89%, ensuring investors are largely shielded from riba-related earnings. While Biogen's current operations and financials are clearly halal, Muslim investors should continue to monitor its debt levels during major acquisitions or clinical trial funding phases. Staying updated on their quarterly financial ratios will ensure the stock remains compliant within AAOIFI boundaries. Biogen Inc. operates in the Healthcare sector under the Drug Manufacturers - General industry and is headquartered in Cambridge, MA, US. The company is led by CEO Christopher A. Viehbacher and employs approximately 7,605 people.
What screening criteria were used for BIIB?
BIIB was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. BIIB passed 4 of these 4 screens.
Does BIIB require income purification?
Although BIIB passes all shariah screens, it does earn $87.8M in interest income (0.89% of revenue). Many scholars recommend purifying this portion by donating the equivalent percentage of any dividends received to charity. For example, if you receive $100 in dividends, you would donate approximately $0.89 to purify the income.
When was BIIB last screened?
BIIB was last screened on 2026-04-29. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.

Disclaimer

This shariah compliance assessment for BIIB (Biogen Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.

Other Halal Stocks in Healthcare